Enrichment of Immature CD10low Neutrophils in Multiple Sclerosis Patients

Overview

This pilot study identified a significant enrichment of immature CD10low neutrophils in the peripheral blood of individuals with recently active multiple sclerosis (MS) or clinically isolated syndrome (CIS) compared to controls. These neutrophils exhibited decreased expression of CD16 and CD11b and lacked CD184, suggesting an immature phenotype potentially linked to active MS disease.

Background

Multiple sclerosis (MS) is an immune-mediated demyelinating disease of the central nervous system, traditionally associated with T and B cell involvement. Emerging evidence suggests neutrophils may contribute to early MS pathogenesis by promoting inflammation, antigen presentation, and blood-brain barrier disruption. Neutrophil subpopulations with distinct phenotypes exist and may vary with disease states, but their specific roles in MS remain poorly characterized. This study applied advanced flow cytometry techniques to explore neutrophil subsets in newly diagnosed MS or CIS patients.

Data Highlights

Key Findings

• CD10low neutrophils were significantly enriched in the blood of people with CIS and MS compared to controls.
• These CD10low neutrophils showed decreased expression of CD16 and CD11b, and absence of CD184, indicating an immature neutrophil phenotype.
• Proportions of CD10low neutrophils in MS patients showed a non-significant trend toward correlation with Expanded Disability Status Scale (EDSS) scores (p=0.06).
• Neutrophil phenotyping was performed rapidly within three hours of blood collection using an optimized multicolor flow cytometry panel (OMIP-100).
• No significant differences in age or sex distribution were observed between CIS/MS and control groups.

Clinical Implications

The identification of immature CD10low neutrophils enriched in early MS suggests these cells may play a role in disease onset or activity. Monitoring this neutrophil subset could potentially serve as a biomarker for active MS episodes. Further functional studies are warranted to elucidate their contribution to MS pathophysiology and to explore their utility in guiding therapeutic interventions.

Conclusion

This study highlights immature CD10low neutrophils as a distinct population enriched in the peripheral blood of individuals with early MS or CIS, warranting further investigation into their role in MS disease mechanisms and biomarker development.

References

1. Original Study -- Enrichment of Immature CD10low Neutrophils in Individuals Diagnosed with Multiple Sclerosis